Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study. - Wikidata - wikimedia - TriplyDB

Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study.

Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study.

http://www.wikidata.org/entity/Q37023430

about

Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study.Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation

P2860

Q33441090-DE65BF1B-502B-49D1-84ED-F317D30A7D2A Q58719404-79075E7C-9EF9-44C4-8D77-C835C826127D

P2860

Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study.

http://www.wikidata.org/entity/Q37023430

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of Kangfuxin Solution o ...... ized Phase III Clinical Study.

@en

Effect of Kangfuxin Solution o ...... ized Phase III Clinical Study.

@nl

type

label

Effect of Kangfuxin Solution o ...... ized Phase III Clinical Study.

@en

Effect of Kangfuxin Solution o ...... ized Phase III Clinical Study.

@nl

prefLabel

Effect of Kangfuxin Solution o ...... ized Phase III Clinical Study.

@en

Effect of Kangfuxin Solution o ...... ized Phase III Clinical Study.

@nl

P1433

Q37023430-987A3673-3A7A-4498-8A9A-27ED58ACDC1C

P1476

Q37023430-55ADA147-CD1F-4B68-89D4-AF7D98A3CCD6

P2093

Q37023430-0CFA9ABD-F740-46C6-B8D6-BBAC161A0A62

Q37023430-0ED1558D-2FBB-40AA-809C-AC443E771191

Q37023430-1C246D5C-FE0F-401D-B614-0684FC521572

Q37023430-3C71DB57-270A-4229-A610-0B0D9C83C978

Q37023430-57E4585B-06E1-4193-85A0-A1729968A03A

Q37023430-59E77168-08C6-4ED5-BE84-1ECF5A0DDF28

Q37023430-9EFE07BB-CEF8-4387-B77E-BF821633A5D9

Q37023430-A3CCA0B6-1E5C-4128-9F6F-F933596883FA

Q37023430-B17E0F31-C0E9-40D0-B9CF-C34B25077A70

Q37023430-C9351C63-5CAB-41D4-9A91-8FD8651F83AA

P2860

Q37023430-0F6C4D78-860D-4A16-9D65-9140A06917F6

Q37023430-195715D4-C4E3-4952-947E-D7EA9EC944BF

Q37023430-2C1CBD89-E360-4F6A-B114-640A0CF08EC4

Q37023430-38AA46FE-3A94-409C-BF39-625F0301312D

Q37023430-471AFA0A-4A48-44C3-BEAD-32C0003BE5A3

Q37023430-5C7E85E9-5308-454C-8582-B7352883BF12

Q37023430-72F85734-05A6-4B83-93C4-EC7045A662E3

Q37023430-78D45D36-EFBC-4313-92D0-E4C3B83928C2

Q37023430-7BED77CE-4651-4AB6-B7E4-CE4721ACDD1C

Q37023430-7E570B26-D6C9-4B1C-A87A-E9698E40D1CE

P304

Q37023430-275E0E3E-F3ED-4FA5-99A0-FC7E92D918B3

P31

Q37023430-4FDAD72E-2EE1-4BE4-BB62-7B82FA56ED30

P356

Q37023430-9D5E8673-9FFB-4388-9D6A-E8128AE6C710

P478

Q37023430-7D65ACE4-93F1-4CAC-810A-3DEFCABCAE96

P50

Q37023430-AA0398CD-0144-49FA-AC18-447E94970C55

P577

Q37023430-318207A3-9BC5-4BA0-8964-D8DD99F2F550

P698

Q37023430-25D2BDBB-F201-4F2F-B0C3-40DBA2195F47

P921

Q37023430-32AA3F70-F900-4F45-A6D1-910D85BB05FF

Q37023430-75D08EB0-999C-4F60-9717-32CF8CD1242A

P932

Q37023430-E7A643F3-8B7A-4EFE-B560-909C2D5B2FD9

P356

P1433

Evidence-based Complementary and Alternative Medicine

P1476

Effect of Kangfuxin Solution o ...... mized Phase III Clinical Study

@en

P2093

Feng Jin

http://www.w3.org/2001/XMLSchema#string

Hongfang Bai

http://www.w3.org/2001/XMLSchema#string

Jingbo Wu

http://www.w3.org/2001/XMLSchema#string

Mei Feng

http://www.w3.org/2001/XMLSchema#string

Qinghua Jiang

http://www.w3.org/2001/XMLSchema#string

Rongqing Li

http://www.w3.org/2001/XMLSchema#string

Xia Yang

http://www.w3.org/2001/XMLSchema#string

Xiaodong Zhu

http://www.w3.org/2001/XMLSchema#string

Yangkun Luo

http://www.w3.org/2001/XMLSchema#string

Yecai Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Palifermin for oral mucositis after intensive therapy for hematologic cancers

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

Mechanisms for radiation-induced oral mucositis and the consequences.

Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis.

The pathobiology of mucositis.

Pain: a review of three commonly used pain rating scales.

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.

Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.

Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.

P304

8692343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/8692343

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27375766

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

multicenter trial

P932

4914730

http://www.w3.org/2001/XMLSchema#string